RE:Unqualified pessimism IS NOT unbiased researchFrost & Sullivan awards ... The inner workings. Judge for yourself.
https://ipvm.com/reports/should-you-trust-frost-&-sullivan-awards and
https://www.complaintsboard.com/complaints/frost-sullivan-c272270.html My conclusion: The reports are prepared at the expense of F&S but the actual acceptance and promotional use of the award comes with a hefty price tag.
Petro-Marine ...
I believe that the real issue isn’t EUO’s failure to turn Petro-Marine into a commercial success. It is EUO’s reluctance / tardiness to communicate this failure in a timely manner and with equal “fanfare” as the August 15, 2013 NR announcing the commencement of the pilot project.
This is no different than a biotech announcing a clinical trial or a dirt digger announcing commencement of a drill program. By publicly announcing events like this, companies commit themselves to publishing timely updates and/or results which EUO seemingly neglected to do. The omission of the P-M target market size statement in the re-filed 2014 MD&A suggests that the pilot had already failed or at least, was not going well at that time and yet it remained as a seemingly ongoing / alive and well project in EUO company presentations right up until March 2016 when it was quietly dropped without explanation of any kind.
Shareholders are entitled to and have to be able to rely on timely and complete disclosure in order to be able to continuously assess the validity of their investments. Failure to provide such disclosure may lead to incorrect risk assessments and thus investment losses. Ensuring proper disclosure is actually part of the BOD’s SEC stipulated “fiduciary duty” to shareholders. I often wonder if public company BOD members are aware of this ...